HTLV-1 (human T-lymphotropic virus type 1) causes chronic infection of human T lymphocytes. HTLV-1 infection is known to be related to multiple diseases, including neoplastic growth of HTLV-1-infected T cells (ATL) and neoplastic inflammatory conditions, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Sjögren’s syndrome with arthritis, polymyositis uveitis, and bronchoalveolitis. Regulatory T cells (Tregs) regulate inflammatory cells, such as Th17 cells. The purpose of this study was to evaluate Tregs and Th17 cells, as well as the expression of related transcription factors (ROR-?t and FOXP3) and cytokines (IL-10, TGF-?, IL-6, and IL-17A) in HTLV-1 infection.
Boostani R, Lotfinejad N, Zemorshidi F, et al., 2021, Planning and Management to Control and Eliminate HTLV-1 Infection in Iran. Iranian Journal of Basic Medical Sciences, 24(3): 264-266.
Araya N, Sato T, Yagishita N, et al., 2011, Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease. Viruses, 3(9): 1532-1548.
Birmann BM, Breen EC, Stuver S, et al., 2009, Population Differences in Immune Marker Profiles Associated with Human T?Lymphotropic Virus Type I Infection in Japan and Jamaica. International Journal of Cancer, 124(3): 614-621.
Tarokhian H, Rahimi H, Mosavat A, et al., 2018, HTLV-1-Host Interactions on the Development of Adult T Cell Leukemia/Lymphoma: Virus and Host Gene Expressions. BMC Cancer, 18(1): 1-12.
Carpentier A, Barez P-Y, Hamaidia M, et al., 2015, Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence. Viruses, 7(7): 3603-3624.
Nagate Y, Ezoe S, Fujita J, et al., 2021, Ectonucleotidase CD39 is Highly Expressed on ATLL Cells and Is Responsible for Their Immunosuppressive Function. Leukemia, 35(1): 107-118.
Higuchi Y, Yasunaga J-i, Mitagami Y, et al., 2020, HTLV-1 Induces T Cell Malignancy and Inflammation by Viral Antisense Factor-Mediated Modulation of the Cytokine Signaling. Proceedings of the National Academy of Sciences, 117(24): 13740-13749.
Koyanagi Y, Itoyama Y, Nakamura N, et al., 1993, In Vivo Infection of Human T-Cell Leukemia Virus Type I in Non-T Cells. Virology, 196(1): 25-33.
Mohammadi S, Abdollahi E, Nezamnia M, et al., 2020, Adoptive Transfer of Tregs: A Novel Strategy for Cell-Based Immunotherapy in Spontaneous Abortion: Lessons from Experimental Models. International Immunopharmacology, 90: 107195.
Lippi G, Lavie CJ, Sanchis-Gomar F, 2020, Cardiac Troponin I in Patients with Coronavirus Disease 2019 (COVID-19): Evidence from a Meta-Analysis. Progress in Cardiovascular Diseases, 63(3): 390-391.
Bhatla A, Mayer MM, Adusumalli S, et al., 2020, COVID-19 and Cardiac Arrhythmias. Heart Rhythm, 17(9): 1439-1444.
Christoffersson G, von Herrath M, 2019, Regulatory Immune Mechanisms Beyond Regulatory T Cells. Trends in Immunology, 40(6): 482-491.
Romano M, Fanelli G, Albany CJ, et al., 2019, Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity. Frontiers in Immunology, 10: 43.
Bouwman W, Verhaegh W, Holtzer L, et al., 2020, Measurement of Cellular Immune Response to Viral Infection and Vaccination. Frontiers in Immunology, 11: 2719.
Jin Y, Wi HJ, Choi M-H, et al., 2014, Regulation of Anti-Inflammatory Cytokines IL-10 and TGF-? in Mouse Dendritic Cells Through Treatment with Clonorchis Sinensis Crude Antigen. Experimental & Molecular Medicine, 46(1): e74.
Sanjabi S, Zenewicz LA, Kamanaka M, et al., 2009, Anti-Inflammatory and Pro-Inflammatory Roles of TGF-?, IL-10, and IL-22 in Immunity and Autoimmunity. Current Opinion in Pharmacology, 9(4): 447-453.
Veldhoen M, Hocking RJ, Atkins CJ, et al., 2006, TGF? in the Context of An Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells. Immunity, 24(2): 179-189.
Konkel JE, Zhang D, Zanvit P, et al., 2017, Transforming Growth Factor-? Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses. Immunity, 46(4): 660-674.
Fujimoto Y, Kuramoto N, Yoneyama M, et al., 2020, Interleukin-19 as An Immunoregulatory Cytokine. Current Molecular Pharmacology, 14(2): 191-199.
Abdollahi E, Tavasolian F, Ghasemi N, et al., 2015, Association Between Lower Frequency of R381Q Variant (Rs11209026) in IL-23 Receptor Gene and Increased Risk of Recurrent Spontaneous Abortion (RSA). Journal of Immunotoxicology, 12(4): 317-321.
Martinez NE, Sato F, Kawai E, et al., 2012, Regulatory T Cells and Th17 Cells in Viral Infections: Implications for Multiple Sclerosis and Myocarditis. Future Virology, 7(6): 593-608.
Castro G, Liu X, Ngo K, et al., 2017, ROR?t and ROR? Signature Genes in Human Th17 Cells. PloS ONE, 12(8): E0181868.
Neco HV, Teixeira VG, Trindade AC, et al., 2017, IL17A Polymorphism Is Not Associated with Human T-Lymphotropic Virus 1-Associated Myelopathy/Tropical Spastic Paraparesis. Viral Immunology, 30(4): 298-301.
Kany S, Vollrath JT, Relja B, 2019, Cytokines in Inflammatory Disease. International Journal of Molecular Sciences, 20(23): 6008.
Hamano R, Wu X, Wang Y, et al., 2015, Characterization of MT-2 Cells as A Human Regulatory T Cell-Like Cell Line. Cellular & Molecular Immunology, 12(6): 780-782.
Meissner ME, Mendonça LM, Zhang W, et al., 2017, Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed Through Characterization of A Chronically Infected Cell Line. Journal of Virology, 91(16): e00369-17.
Satou Y, Yasunaga J-i, Zhao T, et al., 2011, HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo. PloS Pathog, 7(2): e1001274.
Kchour G, Rezaee SR, Farid R, et al., 2013, The Combination of Arsenic, Interferon-Alpha, and Zidovudine Restores An “Immunocompetent-Like” Cytokine Expression Profile in Patients with Adult T-Cell Leukemia Lymphoma. Retrovirology, 10(1): 1-12.
Swaims AY, Khani F, Zhang Y, et al., 2010, Immune Activation Induces Immortalization of HTLV-1 LTR-Tax Transgenic CD4+ T Cells. Blood, 116(16): 2994-3003.
Champs APS, de Azeredo Passos VM, Carvalho G, et al., 2019, Cognitive Impairment in HTLV-1-Associated Myelopathy, Proviral Load and Inflammatory Markers. International Journal of Infectious Diseases, 84: 121-126.
Quaresma JA, Yoshikawa GT, Koyama RV, et al., 2016, HTLV-1, Immune Response and Autoimmunity. Viruses, 8(1): 5.
Eggenhuizen PJ, Ng BH, Ooi JD, 2020, Treg Enhancing Therapies to Treat Autoimmune Diseases. International Journal of Molecular Sciences, 21(19): 7015.
Mohammadi S, Abdollahi E, Nezamnia M, et al., 2021, Adoptive Transfer of Tregs: A Novel Strategy for Cell-Based Immunotherapy in Spontaneous Abortion: Lessons from Experimental Models. International Immunopharmacology, 90: 107195.
Guo K, Zhang X, 2021, Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. Journal of Immunology Research, 2021: 6693542.
Abdollahi E, Tavasolian F, Momtazi-Borojeni AA, et al., 2016, Protective Role of R381Q (rs11209026) Polymorphism in IL-23R Gene in Immune-Mediated Diseases: A Comprehensive Review. Journal of Immunotoxicology, 13(3): 286-300.
Yamano Y, Araya N, Sato T, et al., 2009, Abnormally High Levels of Virus-Infected IFN-?+ CCR4+ CD4+ CD25+ T Cells in A Retrovirus-Associated Neuroinflammatory Disorder. PloS ONE, 4(8): E6517.
Oh U, Grant C, Griffith C, et al., 2006, Reduced Foxp3 Protein Expression Is Associated with Inflammatory Disease During Human T Lymphotropic Virus Type 1 Infection. The Journal of Infectious Diseases, 193(11): 1557-1566.
Satou Y, Matsuoka M, 2010, HTLV-1 and the Host Immune System: How the Virus Disrupts Immune Regulation, Leading to HTLV-1 Associated Diseases. Journal of Clinical and Experimental Hematopathology, 50(1): 1-8.
Toulza F, Heaps A, Tanaka Y, et al., 2008, High Frequency of CD4+ FoxP3+ Cells in HTLV-1 Infection: Inverse Correlation with HTLV-1-Specific CTL Response. Blood. The Journal of the American Society of Hematology, 111(10): 5047-5053.
Brito?Melo G, Peruhype?Magalhaes V, Teixeira?Carvalho A, et al., 2007, IL?10 Produced by CD4+ and CD8+ T Cells Emerge as A Putative Immunoregulatory Mechanism to Counterbalance the Monocyte?Derived TNF?? and Guarantee Asymptomatic Clinical Status During Chronic HTLV?I Infection. Clinical & Experimental Immunology, 147(1): 35-44.
de Sa KSG, Santana BB, de Souza Ferreira TC, et al., 2016, IL28B Gene Polymorphisms and Th1/Th2 Cytokine Levels Might Be Associated with HTLV-Associated Arthropathy. Cytokine, 77: 79-87.
Sasada A, Takaori-Kondo A, Shirakawa K, et al., 2005, APOBEC3G Targets Human T-Cell Leukemia Virus Type 1. Retrovirology, 2(1): 1-10.
Best I, Lopez G, Verdonck K, et al., 2009, IFN?? Production in Response to Tax 161–233, and Frequency of CD4+ Foxp3+ and Lin? HLA?DRhigh CD123+ Cells, Discriminate HAM/TSP Patients from Asymptomatic HTLV?1?Carriers in A Peruvian Population. Immunology, 128(1pt2): e777-e786.
Araujo AQ, Leite ACC, Lima MAS, et al., 2009, HTLV-1 and Neurological Conditions: When to Suspect and When to Order A Diagnostic Test for HTLV-1 Infection?. Arq Neuropsiquiatr, 67(1): 132-138.
Castro-Costa CMd, Araujo AdQC, Camara CC, et al., 2009, Pain in Tropical Spastic Paraparesis/HTLV-I Associated Myelopathy Patients. Arq Neuropsiquiatr, 67(3B): 866-870.